10-Q · May 5, 2026
JBT Marel Corporation's Q1 2026 results showed strong financial performance, with revenue increasing to $936 million, a 9.6% jump year-over-year, and EPS rising to $1.58, outperforming estimates. The company also…
Earnings analysis · 10-Q
JBTM earnings analysis
Filed November 3, 2026 · Our reading of the company's report
The latest report
JBT Marel reported Q3 revenue of $994 million and EPS of $2.19, with EPS above the $2.10 estimate but revenue below the $1.029 billion estimate. Capital returns increased, including 800,855 shares repurchased in August…
Read full summary
JBT Marel reported Q3 revenue of $994 million and EPS of $2.19, with EPS above the $2.10 estimate but revenue below the $1.029 billion estimate. Capital returns increased, including 800,855 shares repurchased in August and a board-approved increase that brought total repurchase authorization to $700 million. The principal 10-Q concern is that disclosure controls remained ineffective as of September 30, 2026 because Marel’s IT and journal-entry control weaknesses remained unremediated; the filing reported no material changes to risk factors from the December 31, 2025 10-K.
Reported figures
- Earnings per share
- $2.19
What stood out
-
EPS beat despite revenue shortfall
Q3 revenue was $994 million and reported EPS was $2.19. EPS exceeded the $2.10 estimate, while revenue was below the $1.029 billion estimate.
-
Share repurchases continued
The company repurchased 800,855 shares during August 2026 at an average price of $117.59 per share. Approximately $80 million remained under the $200 million program as of September 30, 2026.
-
Repurchase authorization expanded
On October 30, 2026, the board authorized a $500 million increase to the repurchase program, bringing total authorization to $700 million.
What to watch
-
Disclosure controls remain ineffective
Disclosure controls were ineffective as of September 30, 2026 because material weaknesses in Marel’s internal control over financial reporting remained unremediated.
-
Unremediated IT control deficiencies
Marel’s information-technology control weaknesses remained unremediated as of September 30, 2026, including deficiencies in access, change management, computer operations, and program development controls. The company states these deficiencies could affect controls supporting all financial statement accounts and disclosures.
-
Journal-entry control weakness persists
Marel lacked effective controls over journal-entry validity, accuracy, and completeness as of September 30, 2026; certain accounting personnel could prepare and post entries without appropriately designed independent review. The company reported that these weaknesses had resulted in immaterial misstatements for the three months ended March 31, 2025.
-
Remediation remains incomplete
Management said additional time is required to complete control testing and determine whether remediation is effective; the material weaknesses will not be considered remediated until controls operate for a sufficient period and pass testing.
Management's outlook
The provided 10-Q excerpt does not include quantitative revenue or EPS guidance, nor a comparison with prior outlook. Numeric outlook was discussed in the separate November 3, 2026 earnings disclosure, not in the supplied 10-Q text.
Earlier filings 1
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.